Correlation Between BICO Group and Xvivo Perfusion

Can any of the company-specific risk be diversified away by investing in both BICO Group and Xvivo Perfusion at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BICO Group and Xvivo Perfusion into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BICO Group AB and Xvivo Perfusion AB, you can compare the effects of market volatilities on BICO Group and Xvivo Perfusion and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BICO Group with a short position of Xvivo Perfusion. Check out your portfolio center. Please also check ongoing floating volatility patterns of BICO Group and Xvivo Perfusion.

Diversification Opportunities for BICO Group and Xvivo Perfusion

-0.36

Correlation Coefficient

BICO Group  Xvivo Perfusion

Very good diversification

The 3 months correlation between BICO and Xvivo is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding BICO Group AB and Xvivo Perfusion AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xvivo Perfusion AB and BICO Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BICO Group AB are associated (or correlated) with Xvivo Perfusion. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xvivo Perfusion AB has no effect on the direction of BICO Group i.e., BICO Group and Xvivo Perfusion go up and down completely randomly.

Pair Corralation between BICO Group and Xvivo Perfusion

Assuming the 90 days trading horizon BICO Group AB is expected to generate 1.45 times more return on investment than Xvivo Perfusion. However, BICO Group is 1.45 times more volatile than Xvivo Perfusion AB. It trades about 0.02 of its potential returns per unit of risk. Xvivo Perfusion AB is currently generating about -0.24 per unit of risk. If you would invest  3,202  in BICO Group AB on December 30, 2024 and sell it today you would lose (12.00) from holding BICO Group AB or give up 0.37% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

BICO Group AB  vs.  Xvivo Perfusion AB

BICO Group AB

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in BICO Group AB are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, BICO Group is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Xvivo Perfusion AB

Risk-Adjusted Performance

Very Weak

Over the last 90 days Xvivo Perfusion AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with BICO Group and Xvivo Perfusion

The main advantage of trading using opposite BICO Group and Xvivo Perfusion positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BICO Group position performs unexpectedly, Xvivo Perfusion can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xvivo Perfusion will offset losses from the drop in Xvivo Perfusion's long position.

The idea behind BICO Group AB and Xvivo Perfusion AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.